Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

LJC 10627

Known as: LJC-10627, LJC10,627 
 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

biapenem

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
In vitro antibacterial activity and beta-lactamase stability of the new carbapenem LJC10,627
In in vitro susceptibility tests the new carbapenem LJC10,627 showed potent antibacterial activity against gram-positive and gram… Expand
  • figure 1
  • table 1
  • table 1
  • table 2
  • table 3
Is this relevant?
1994
1994
In-vitro activity of biapenem, compared with imipenem and meropenem, against Pseudomonas aeruginosa strains and mutants with known resistance mechanisms.
The activity of biapenem (L-627, LJC-10627), a new carbapenem, was investigated against Pseudomonas aeruginosa strains, mutants… Expand
Is this relevant?
1991
1991
In vitro and in vivo activities of LJC10,627, a new carbapenem with stability to dehydropeptidase I.
The activity of LJC10,627 was compared with the activities of imipenem and other antibiotics. LJC10,627 was more active against… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
1990
Highly Cited
1990
In vitro activity of LJC10,627, a new carbapenem antibiotic with high stability to dehydropeptidase I.
The in vitro activity of LJC10,627, a new carbapenem, was compared with those of imipenem and ceftazidime. LJC10,627 had broad… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE